Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2019-12-13 13:10 Tx date 2019-12-13 |
$CORV
Correvio Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-3,368
-8,420 vol $0.40 each |
0 | |
Filed 2019-06-27 18:54 Tx date 2019-06-25 |
$CORV
Correvio Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$46,200
+20,000 vol $2.31 each |
75,100 | |
Filed 2018-06-20 Tx date 2018-06-19 |
$CORV
Correvio Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$73,600
+20,000 vol $3.68 each |
55,100 | |
Filed 2018-06-20 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
8,420 | ||
Filed 2018-06-20 Tx date 2018-05-25 |
$CORV
Correvio Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
35,100 | ||
Filed 2017-08-28 Tx date 2017-08-25 |
$COM
Cardiome Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,420
+2,000 vol $2.21 each |
5,920 | |
Filed 2017-08-18 Tx date 2017-08-14 |
$COM
Cardiome Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$49,000
+12,500 vol $3.92 each |
35,100 | |
Filed 2016-08-15 Tx date 2016-08-11 |
$COM
Cardiome Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$38,500
+12,500 vol $3.08 each |
22,600 | |
Filed 2016-08-15 Tx date 2016-08-15 |
$COM
Cardiome Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,700
+3,920 vol $3.24 each |
3,920 | |
Filed 2016-08-15 Tx date 2015-08-31 |
$COM
Cardiome Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-09-30 Tx date 2015-09-25 |
$COM
Cardiome Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$98,374
+10,100 vol $9.74 each |
10,100 | |
Filed 2015-09-30 Tx date 2015-08-31 |
$COM
Cardiome Pharma Corp. |
Meyer, Robert James
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|